TRPC6 channel activation promotes neonatal glomerular mesangial cell apoptosis via calcineurin/NFAT and FasL/Fas signaling pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Soni, Hitesh ^a   Adebiyi, Adebowale ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2-BIS(2-AMINOPHENOXY)ETHANE-N,N,N',N'-TETRAACETIC ACID; CALCINEURIN; CALCIUM; CASPASE 8; CASPASE INHIBITOR; EGTAZIC ACID; FAS LIGAND; HYPERFORIN; OLIGOPEPTIDE; PHLOROGLUCINOL; SMALL INTERFERING RNA; TERPENE; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 6; VIVIT PEPTIDE;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CALCIUM SIGNALING; CELL CULTURE; CELL DIVISION; DRUG EFFECT; GENETICS; ION TRANSPORT; MESANGIUM CELL; METABOLISM; NEWBORN; OXIDATIVE STRESS; PHYSIOLOGY; PIG; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CALCINEURIN; CALCIUM; CALCIUM SIGNALING; CASPASE 8; CASPASE INHIBITORS; CELL DIVISION; CELLS, CULTURED; EGTAZIC ACID; FAS LIGAND PROTEIN; FAS RECEPTOR; ION TRANSPORT; MESANGIAL CELLS; NFATC TRANSCRIPTION FACTORS; OLIGOPEPTIDES; OXIDATIVE STRESS; PHLOROGLUCINOL; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUS SCROFA; TERPENES; TRPC6 CATION CHANNEL;

EID: 84977648048     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29041     Document Type: Article

References (59)

1. Schlondorff, D. & Banas, B. The mesangial cell revisited: no cell is an island. J. Am. Soc. Nephrol. 20, 1179-1187 (2009).
2. Baker, A. J. et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin. Invest 94, 2105-2116 (1994).
3. Mauer, S. M. et al. Structural-functional relationships in diabetic nephropathy. J. Clin. Invest 74, 1143-1155 (1984).
4. Steffes, M. W., Osterby, R., Chavers, B. & Mauer, S. M. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38, 1077-1081 (1989).
5. Habib, R. Nephrotic syndrome in the 1st year of life. Pediatr. Nephrol. 7, 347-353 (1993).
6. Saleh, H., Schlatter, E., Lang, D., Pauels, H. G. & Heidenreich, S. Regulation of mesangial cell apoptosis and proliferation by intracellular Ca2+ signals. Kidney Int. 58, 1876-1884 (2000).
7. Stockand, J. D. & Sansom, S. C. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev. 78, 723-744 (1998).
8. Ma, R., Pluznick, J. L. & Sansom, S. C. Ion channels in mesangial cells: function, malfunction, or fiction. Physiology. (Bethesda.) 20, 102-111 (2005).
9. Dryer, S. E. & Reiser, J. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology. Am. J Physiol Renal Physiol 299, F689-F701 (2010).
10. Schlondorff, J. S. & Pollak, M. R. TRPC6 in glomerular health and disease: what we know and what we believe. Semin. Cell Dev. Biol. 17, 667-674 (2006).
11. Reiser, J. et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 37, 739-744 (2005).
12. Winn, M. P. et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308, 1801-1804 (2005).
13. Ilatovskaya, D. V. et al. Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels. Sci. Rep 5, 17637 (2015).
14. Graham, S. et al. Downregulation of TRPC6 protein expression by high glucose, a possible mechanism for the impaired Ca2+ signaling in glomerular mesangial cells in diabetes. Am. J. Physiol Renal Physiol 293, F1381-F1390 (2007).
15. Qiu, G. & Ji, Z. AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration. Clin. Exp. Med 14, 169-176 (2014).
16. Kong, F. et al. Alpha1-Adrenergic Receptor Activation Stimulates Calcium Entry and Proliferation via TRPC6 Channels in Cultured Human Mesangial Cells. Cell Physiol Biochem. 36, 1928-1938 (2015).
17. Liao, C. et al. The upregulation of TRPC6 contributes to Ca2+ signaling and actin assembly in human mesangial cells after chronic hypoxia. Biochem. Biophys. Res. Commun. 421, 750-756 (2012).
18. Rao, A., Luo, C. & Hogan, P. G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15, 707-747 (1997).
19. Horsley, V. & Pavlath, G. K. NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol. 156, 771-774 (2002).
20. Im, S. H. & Rao, A. Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol. Cells 18, 1-9 (2004).
21. Nijenhuis, T. et al. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am. J Pathol. 179, 1719-1732 (2011).
22. Kuwahara, K. et al. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J Clin. Invest 116, 3114-3126 (2006).
23. Schlondorff, J., Del, C. D., Carrasquillo, R., Lacey, V. & Pollak, M. R. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription. Am. J Physiol Cell Physiol 296, C558-C569 (2009).
24. Wang, Y. et al. Activation of NFAT signaling in podocytes causes glomerulosclerosis. J Am. Soc. Nephrol. 21, 1657-1666 (2010).
25. Ding, Y. et al. Reactive oxygen species-mediated TRPC6 protein activation in vascular myocytes, a mechanism for vasoconstrictorregulated vascular tone. J Biol. Chem. 286, 31799-31809 (2011).
26. Leuner, K. et al. Hyperforin-a key constituent of St. John's wort specifically activates TRPC6 channels. FASEB J. 21, 4101-4111 (2007).
27. Muller, M. et al. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol. Chem. 283, 33942-33954 (2008).
28. Ikeda, K. et al. Roles of transient receptor potential canonical (TRPC) channels and reverse-mode Na+/Ca2+ exchanger on cell proliferation in human cardiac fibroblasts: effects of transforming growth factor beta1. Cell Calcium 54, 213-225 (2013).
29. Leuner, K. et al. Hyperforin modulates dendritic spine morphology in hippocampal pyramidal neurons by activating Ca2+- permeable TRPC6 channels. Hippocampus 23, 40-52 (2013).
30. Leuner, K. et al. Simple 2,4-diacylphloroglucinols as classic transient receptor potential-6 activators-identification of a novel pharmacophore. Mol. Pharmacol. 77, 368-377 (2010).
31. Whiteside, C., Munk, S., Zhou, X., Miralem, T. & Templeton, D. M. Chelation of intracellular calcium prevents mesangial cell proliferative responsiveness. J Am. Soc. Nephrol. 9, 14-25 (1998).
32. Nagata, S. Fas ligand-induced apoptosis. Annu. Rev. Genet. 33, 29-55 (1999).
33. Boyle, J. J. Human macrophages kill human mesangial cells by Fas-L-induced apoptosis when triggered by antibody via CD16. Clin. Exp. Immunol. 137, 529-537 (2004).
34. Pinkoski, M. J. & Green, D. R. Fas ligand, death gene. Cell Death. Differ. 6, 1174-1181 (1999).
35. Kavurma, M. M. & Khachigian, L. M. Signaling and transcriptional control of Fas ligand gene expression. Cell Death. Differ. 10, 36-44 (2003).
36. Merhi, F. et al. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells. PLoS. One. 6, e25963 (2011).
37. Hostanska, K., Reichling, J., Bommer, S., Weber, M. & Saller, R. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Eur. J Pharm. Biopharm. 56, 121-132 (2003).
38. Graham, S. et al. Abundance of TRPC6 protein in glomerular mesangial cells is decreased by ROS and PKC in diabetes. Am. J. Physiol Cell Physiol 301, C304-C315 (2011).
39. Clapham, D. E. TRP channels as cellular sensors. Nature 426, 517-524 (2003).
40. Vazquez, G., Wedel, B. J., Aziz, O., Trebak, M. & Putney, J. W. Jr. The mammalian TRPC cation channels. Biochim. Biophys. Acta 1742, 21-36 (2004).
41. Ohba, T. et al. Upregulation of TRPC1 in the development of cardiac hypertrophy. J Mol. Cell Cardiol. 42, 498-507 (2007).
42. Makarewich, C. A. et al. Transient receptor potential channels contribute to pathological structural and functional remodeling after myocardial infarction. Circ. Res. 115, 567-580 (2014).
43. Abkhezr, M. et al. Pleiotropic signaling evoked by tumor necrosis factor in podocytes. Am. J Physiol Renal Physiol 309, F98-108 (2015).
44. Nagata, S. & Golstein, P. The Fas death factor. Science 267, 1449-1456 (1995).
45. Kischkel, F. C. et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol. Chem. 276, 46639-46646 (2001).
46. Boldin, M. P. et al. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol. Chem. 270, 7795-7798 (1995).
47. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. & Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512 (1995).
48. Kischkel, F. C. et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DiSC) with the receptor. EMBO J 14, 5579-5588 (1995).
49. Kalivendi, S. V. et al. Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium. Biochem. J 389, 527-539 (2005).
50. Chai, W. R., Wang, Q. & Gao, H. B. NFAT2 is implicated in corticosterone-induced rat Leydig cell apoptosis. Asian J Androl 9, 623-633 (2007).
51. Srivastava, R. K., Sasaki, C. Y., Hardwick, J. M. & Longo, D. L. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J Exp. Med 190, 253-265 (1999).
52. Jayanthi, S. et al. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamineinduced neuronal apoptosis. Proc. Natl. Acad. Sci. USA 102, 868-873 (2005).
53. Tu, P., Gibon, J. & Bouron, A. The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria. J Neurochem. 112, 204-213 (2010).
54. Friedland, K. & Harteneck, C. Hyperforin: To Be or Not to Be an Activator of TRPC(6). Rev. Physiol Biochem. Pharmacol. 169, 1-24 (2015).
55. Sell, T. S., Belkacemi, T., Flockerzi, V. & Beck, A. Protonophore properties of hyperforin are essential for its pharmacological activity. Sci. Rep 4, 7500 (2014).
56. Babcock, D. F., Herrington, J., Goodwin, P. C., Park, Y. B. & Hille, B. Mitochondrial participation in the intracellular Ca2+ network. J Cell Biol. 136, 833-844 (1997).
57. Walsh, C. et al. Modulation of calcium signalling by mitochondria. Biochim. Biophys. Acta 1787, 1374-1382 (2009).
58. Adebiyi, A., Soni, H., John, T. A. & Yang, F. Lipid rafts are required for signal transduction by angiotensin II receptor type 1 in neonatal glomerular mesangial cells. Exp. Cell Res. 324, 92-104 (2014).
59. Adebiyi, A. RGS2 regulates urotensin II-induced intracellular Ca2+ elevation and contraction in glomerular mesangial cells. J. Cell Physiol 229, 502-511 (2014).